Not applicableStudy completedNCT03326089What this trial is testingPulmonary Rehabilitation in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Corfu General Hospital 20
Not applicableLooking for participantsNCT06528418What this trial is testingIdentification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathWho this might be right forLung CancerLung InfectionCOPD+13 more ChromX Health 10,000
Early research (Phase 1)Study completedNCT04069143What this trial is testingEvaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327Who this might be right forHealthy ParticipantsIdiopathic Pulmonary Fibrosis (IPF) Bristol-Myers Squibb 14
Not applicableEnrolling By InvitationNCT06885515What this trial is testingTelomeres Length in Israeli Fibrotic ILD PatientsWho this might be right forPulmonary Fibrosis Barzilai Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT06331624What this trial is testingBiomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPFWho this might be right forIdiopathic Pulmonary FibrosisIPF GRI Bio Operations, Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT00467831What this trial is testingPilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak SyndromeWho this might be right forHermansky-Pudlak Syndrome (HPS)Pulmonary FibrosisOculocutaneous Albinism+2 more National Human Genome Research Institute (NHGRI) 3
Not applicableStudy completedNCT04864990What this trial is testingDyspnea and Idiopathic Pulmonary FibrosisWho this might be right forPulmonary Fibrosis University Hospital, Lille 51
Not applicableNo Longer AvailableNCT02230982What this trial is testingExpanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim
Very early researchLooking for participantsNCT06853145What this trial is testingHyperpolarized Xenon-129 MRI in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis University of Virginia 6
Post-approval studies (Phase 4)UnknownNCT03260556What this trial is testingPirfenidone for Progressive Fibrotic SarcoidosisWho this might be right forSarcoidosis, Pulmonary University of Cincinnati 60
Not applicableNot Yet RecruitingNCT07627594What this trial is testingSafety of Bronchoscopy in Patients With Interstitial Lung DiseaseWho this might be right forInterstitial Lung Disease (ILD)BronchoscopyBronchoalveolar Lavage (BAL)+5 more University of Milan 427
Not applicableStudy completedNCT04177251What this trial is testingCardiovascular Fibrosis in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary FibrosisCardiac FibrosisArterial Fibrosis San Gerardo Hospital 100
Not applicableStudy completedNCT05113654What this trial is testingSleep Disorders in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Wissenschaftliches Institut Bethanien e.V 78
Testing effectiveness (Phase 2)Study completedNCT02036970What this trial is testingBardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATWho this might be right forPulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more Biogen 166
Testing effectiveness (Phase 2)UnknownNCT05118256What this trial is testingPirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated SilicosisWho this might be right forSilicosisProgressive Massive FibrosisComplicated Silicosis Instituto de investigación e innovación biomédica de Cádiz 18
Not applicableLooking for participantsNCT02852928What this trial is testingEuropean Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and BiobankWho this might be right forLung Diseases, InterstitialPulmonary Alveolar ProteinosisPulmonary Eosinophilia+3 more Matthias Griese 1,000
Early research (Phase 1)Looking for participantsNCT06821464What this trial is testingA Trial of HRS-9813 in Healthy SubjectsWho this might be right forIdiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis Guangdong Hengrui Pharmaceutical Co., Ltd 60
Not applicableStudy completedNCT05784207What this trial is testingAn In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical DoctorsWho this might be right forIdiopathic Pulmonary FibrosisInterstitial Lung DiseaseRadiomics Maastricht University 145
Testing effectiveness (Phase 2)Study completedNCT05722964What this trial is testingStudy on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Guangdong Hengrui Pharmaceutical Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT02477709What this trial is testingAssess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 6